Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: MGC Pharmaceuticals consideration shares sold to cover tax

3rd Feb 2022 16:08

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis - Reports that Nadya Lisovoder sold 22.1 million shares at an average price of AUD0.055, worth AUD1.2 million, about GBP636,500, in three transactions on the Australia Stock Exchange in September last year. In May, Lisovoder had sold her pharmaceutical research business MediCaNL Inc to MGC, and the shares sold in September were part of the consideration shares she had received. They were sold to coverage capital gains tax related to the sale of MediCaNL, MGC says.

Current stock price in Sydney: AUD0.033

12-month change: up 10%

By Tom Waite; [email protected]

Copyright 2022 Alliance News Limited. All Rights Reserved.


Related Shares:

MXC.L
FTSE 100 Latest
Value8,809.74
Change53.53